ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,280.67
-0.01%
Dow Jones
44,974.73
0.56%
Gold vs US Dollar
2,662.08
0.88%
Brent Oil
72.88
0.28%
Bitcoin
98,205.85
2.66%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Heron Therapeautics Inc (HRTX) Share Price

HRTX Heron Therapeautics Inc

1.205
0.045 (3.88%)
Last Updated: 16:24:32
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Heron Therapeautics Inc NASDAQ:HRTX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.045 3.88 1.205 1.20 1.21 1.22 1.17 1.18 412,161 16:24:32   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 127.04M -110.56M -0.7269 -1.64 176.43M
 Type  Size  Price  Time  Units 
  100 1.205 16:24:32 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore HRTX News
12/11/202413:06EDGAR2Form 8-K - Current report
12/11/202412:55PRNUSHeron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance
06/11/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
05/11/202417:41EDGAR2Form 3 - Initial statement of beneficial ownership of securities
04/11/202422:09EDGAR2Form 8-K - Current report
04/11/202422:00PRNUSHeron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
29/10/202420:05PRNUSHeron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024
Period
Draw mode
Data Downloads for HRTX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Heron Therapeautics Inc Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Silver

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years £903.96 only £451.98